Charles River Laboratories International Inc. (NYSE: CRL) has a price-to-earnings ratio that is above its average at 24.71x. The stock has a 36-month beta value of 1.44. Opinions on the stock are mixed, with 3 analysts rating it as a “buy,” 5 as “overweight,” 8 as “hold,” and 0 as “sell.”
The public float for CRL is 50.25M, and at present, short sellers hold a 3.15% of that float. On April 19, 2024, the average trading volume of CRL was 533.15K shares.
CRL) stock’s latest price update
The stock of Charles River Laboratories International Inc. (NYSE: CRL) has decreased by -1.10 when compared to last closing price of 230.09. Despite this, the company has experienced a -7.66% fall in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-04-16 that Investors are optimistic about Charles River (CRL) owing to strength in RMS and DSA segments.
CRL’s Market Performance
CRL’s stock has fallen by -7.66% in the past week, with a monthly drop of -14.62% and a quarterly rise of 10.40%. The volatility ratio for the week is 3.15% while the volatility levels for the last 30 days are 2.49% for Charles River Laboratories International Inc. The simple moving average for the past 20 days is -11.20% for CRL’s stock, with a 5.52% simple moving average for the past 200 days.
Analysts’ Opinion of CRL
TD Cowen, on the other hand, stated in their research note that they expect to see CRL reach a price target of $212. The rating they have provided for CRL stocks is “Market Perform” according to the report published on September 13th, 2023.
Citigroup gave a rating of “Neutral” to CRL, setting the target price at $225 in the report published on July 10th of the previous year.
CRL Trading at -9.68% from the 50-Day Moving Average
After a stumble in the market that brought CRL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -17.25% of loss for the given period.
Volatility was left at 2.49%, however, over the last 30 days, the volatility rate increased by 3.15%, as shares sank -15.15% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +3.20% upper at present.
During the last 5 trading sessions, CRL fell by -7.66%, which changed the moving average for the period of 200-days by +9.05% in comparison to the 20-day moving average, which settled at $254.21. In addition, Charles River Laboratories International Inc. saw -3.74% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CRL starting from Knell Michael Gunnar, who sale 808 shares at the price of $267.52 back on Mar 08 ’24. After this action, Knell Michael Gunnar now owns 7,024 shares of Charles River Laboratories International Inc., valued at $216,156 using the latest closing price.
Knell Michael Gunnar, the CSVP&Chief Accounting Officer of Charles River Laboratories International Inc., sale 2,750 shares at $261.05 during a trade that took place back on Mar 04 ’24, which means that Knell Michael Gunnar is holding 7,832 shares at $717,890 based on the most recent closing price.
Stock Fundamentals for CRL
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.36 for the gross margin
The net margin for Charles River Laboratories International Inc. stands at 0.11. The total capital return value is set at 0.09. Equity return is now at value 14.44, with 6.01 for asset returns.
Based on Charles River Laboratories International Inc. (CRL), the company’s capital structure generated 0.49 points at debt to capital in total, while cash flow to debt ratio is standing at 0.19. The debt to equity ratio resting at 0.98. The interest coverage ratio of the stock is 4.52.
Currently, EBITDA for the company is 1.03 billion with net debt to EBITDA at 2.7. When we switch over and look at the enterprise to sales, we see a ratio of 3.51. The receivables turnover for the company is 5.29for trailing twelve months and the total asset turnover is 0.5. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.52.
Conclusion
To sum up, Charles River Laboratories International Inc. (CRL) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
